NCT02000817 2019-06-24Investigation of Otelixizumab in New-Onset, Autoimmune Type 1 Diabetes Mellitus PatientsGlaxoSmithKlinePhase 1/2 Completed30 enrolled 21 charts
NCT00587132 2013-06-24Secretin (ChiRhoStim) Pancreas Perfusion for Pancreatic AdenocarcinomaMayo ClinicPhase 1/2 Terminated4 enrolled 2 charts